Visalytics
Visalytics
approved EB-2 (NIW)

R&D Scientist

Biomedical Engineering · Greece · 2023-02-01

Processing Time
117 days
Decision Date
2023-02-01
Location
Washington
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design technological infrastructure for new, cost-effective, industry-grade tools that interface with and house human tissue. This work focuses on advancing the development of novel disease treatments and vaccines by modeling human tissues and their response to vaccination agents.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has national importance for its role in treating cardiac/neural conditions and developing vaccines for viruses like COVID-19.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to 3 years of direct research, 6 publications, 130 citations, and multiple patents/patent applications.

3 Waiver Benefit Met

On balance, the U.S. benefits from waiving the job offer requirement because the work optimizes costs for cell culture testing and has cross-industry applications in defense and automotive sectors.

Why This Petition Was Approved

The petition was approved based on 6 peer-reviewed journal articles, 130 citations, 2 U.S. patents, and 4 expert recommendation letters. The evidence demonstrated the work's national importance through funding from the NSF, NIH, and Howard Hughes Medical Institute, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
Georgia 146 days 2025-01-09
The petitioner proposes to continue conducting research and developing novel strategies and therapies to target various diseases, including cancer, autoimmune diseases, and infectious diseases, to enhance biotechnology for cancer therapy and vaccine development.
View Case

Research Scientist

Materials Science · Pakistan

WeGreened EB-2 (NIW) approved
293 days 2025-03-12
The petitioner proposes to identify ideal materials for biomedical applications and develop innovative cancer drugs. The work focuses on enhancing the quality and accessibility of medical treatments through advancements in artificial heart valves, dental implants, and joint replacements. The research aims to improve patient outcomes and enhance the safety and stability of medical implants.
View Case

Scientist

Biotechnology · Dominican Republic

WeGreened EB-2 (NIW) approved
Massachusetts 8 days 2024-01-30
The petitioner proposes to continue her research in the field of biomedical engineering, focusing on the development of scientific tools and methodologies to enhance diagnostic capabilities and improve healthcare delivery. Her work involves advancing biotechnological innovations that address critical domestic healthcare needs and strengthen national competitiveness.
View Case

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Greece

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 117 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Greece All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist